296 related articles for article (PubMed ID: 31321417)
1. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.
Li D; Yoshida K; Feldman CH; Speyer C; Barbhaiya M; Guan H; Solomon DH; Everett BM; Costenbader KH
Rheumatology (Oxford); 2020 Mar; 59(3):495-504. PubMed ID: 31321417
[TBL] [Abstract][Full Text] [Related]
2. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
[TBL] [Abstract][Full Text] [Related]
3. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
Barbhaiya M; Feldman CH; Guan H; Gómez-Puerta JA; Fischer MA; Solomon DH; Everett B; Costenbader KH
Arthritis Rheumatol; 2017 Sep; 69(9):1823-1831. PubMed ID: 28598016
[TBL] [Abstract][Full Text] [Related]
4. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
Choi MY; Li D; Feldman CH; Yoshida K; Guan H; Kim SC; Everett BM; Costenbader KH
Rheumatology (Oxford); 2021 Aug; 60(8):3789-3798. PubMed ID: 33369672
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
6. Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients.
Barbhaiya M; Feldman CH; Chen SK; Guan H; Fischer MA; Everett BM; Costenbader KH
Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1431-1439. PubMed ID: 32475049
[TBL] [Abstract][Full Text] [Related]
7. Mortality in SLE patients compared with population controls in Finland in years 2000-2015.
Elfving P; Kariniemi S; Kautiainen H; Virta LJ; Kaipiainen-Seppänen O; Puolakka K
Rheumatology (Oxford); 2021 Sep; 60(9):4238-4244. PubMed ID: 33404636
[TBL] [Abstract][Full Text] [Related]
8. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
Ingvarsson RF; Landgren AJ; Bengtsson AA; Jönsen A
Lupus; 2019 Oct; 28(12):1488-1494. PubMed ID: 31551031
[TBL] [Abstract][Full Text] [Related]
9. Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
Garg S; Bartels CM; Bao G; Helmick CG; Drenkard C; Lim SS
J Rheumatol; 2023 Jan; 50(1):84-92. PubMed ID: 35914786
[TBL] [Abstract][Full Text] [Related]
10. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
[TBL] [Abstract][Full Text] [Related]
11. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan.
Chen YM; Lin CH; Chen HH; Chang SN; Hsieh TY; Hung WT; Hsieh CW; Lai KL; Lan JL; Chen DY; Lan TH
Rheumatology (Oxford); 2014 Jan; 53(1):180-5. PubMed ID: 24136069
[TBL] [Abstract][Full Text] [Related]
12. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
Lertratanakul A; Wu P; Dyer A; Urowitz M; Gladman D; Fortin P; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Merrill J; Wallace DJ; Ginzler E; Khamashta M; Bruce I; Nived O; Sturfelt G; Steinsson K; Manzi S; Dooley MA; Kalunian K; Petri M; Aranow C; Font J; van Vollenhoven R; Stoll T; Ramsey-Goldman R
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1167-76. PubMed ID: 24470118
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
14. Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.
Aviña-Zubieta JA; To F; Vostretsova K; De Vera M; Sayre EC; Esdaile JM
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):849-856. PubMed ID: 28129475
[TBL] [Abstract][Full Text] [Related]
15. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
[TBL] [Abstract][Full Text] [Related]
16. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
17. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
18. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
[TBL] [Abstract][Full Text] [Related]
19. Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population-Based Study.
Li L; Xie H; Lu N; Esdaile JM; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):259-265. PubMed ID: 31758639
[TBL] [Abstract][Full Text] [Related]
20. Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.
Wu G; Jia X; Gao D; Zhao Z
Clin Rheumatol; 2014 Jul; 33(7):947-53. PubMed ID: 24794488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
